1.	Phase III Randomized Study of Epoetin Alfa versus Placebo in Anemic Patients Receiving Chemotherapy for Stage IV Metastatic Breast Cancer (Summary Last Modified 02/1999) Phase: Phase III Type: Supportive care Status: Completed Age: 18-80 Sponsor: NCI Protocol IDs: RPCI-DS-97-10, ORTHO-PR-96-27-004, NCI-G98-1394
2.	AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid Malignancies Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 20040156, NCT00135317
3.	Phase II Study of EPO with Radiotherapy and CDDP for Stage IIB/III/IVA Cervical Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: adult Sponsor: NCI Protocol IDs: SWOG-9318